In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cellzome gets €30mm with Series C private placement

Executive Summary

Cellzome (functional proteomics start-up) has raised €30mm ($32mm) with its Series C private placement. Lead investor Invesco Private Capital was joined by new investors BioFrontier Partners, SG Asset Management, and Yamanouchi Venture Capital. Existing investors included Advent International, Atlas Venture, Index Ventures, Heidelberg Innovation, Schroder Ventures Life Sciences, Sofinnova Partners, and Stelios Papadopoulos, vice chairman of SG Cowen, which also acted as placement agent for the financing.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies